The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis

The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis

Introduction: Different DNA and RNA viruses exploit common strategies to support their persistence and replication in infected individuals. In particular, the hepatitis B virus (HBV) and the hepatitis C virus (HCV) cause major health problems worldwide. These pathogens exert an immunosuppressive rol...

Full description

Bibliographic Details
Main Authors:	Sirio Fiorino, Carmela Cursaro, Stefania Lorenzini, Elisabetta Loggi, Lucia Brodosi, Laura Cattani, Andrea Cuppini, Mauro Bernardi, Pietro Andreone
Format:	Article
Language:	English
Published:	PAGEPress Publications 2013-03-01
Series:	Italian Journal of Medicine
Subjects:	Prostaglandin E2 Hepatitis B Virus Hepatitis C Virus Chronic hepatitis Non-steroidal antiinflammatory drugs (NSAIDs).
Online Access:	http://www.italjmed.org/index.php/ijm/article/view/131

Similar Items

HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC
by: Chiao-Ling Li, et al.
Published: (2025-01-01)

HCV and HBV genotypes: vital in the progression of HCV/ HBV co-infection
by: Yasmin Badshah, et al.
Published: (2025-01-01)

The infection with HBV and HCV and their relationship to ABO blood group among blood donors
by: Omar A. A. Aljooani, et al.
Published: (2012-04-01)

Treatment Options for Hepatitis A and E: A Non-Systematic Review
by: Filippo Gabrielli, et al.
Published: (2023-04-01)

Results of the National Study of CLEIA Method for the Prevalence of HBV and HCV in the 40-64 Age Population of Mongolia
by: Uranbaigali Enkhbayar, et al.
Published: (2019-09-01)

HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy
by: Antonio Salvio, et al.
Published: (2012-01-01)

Bulevirtide plus Tenofovir Disoproxil Fumarate Improves Liver Function in HDV/HBV Related Cirrhosis after Virological Response: A Case Report
by: Nikolaos Papadopoulos, et al.
Published: (2022-10-01)

Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV
by: Roberto Mateo, et al.
Published: (2023-11-01)

Donated Blood Screening for HIV, HCV and HBV by ID-NAT and the Residual Risk of Iatrogenic Transmission in a Tertiary Care Hospital Blood Bank in Puebla, Mexico
by: Francisca Sosa-Jurado, et al.
Published: (2023-06-01)

Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil
by: Alexandre Martins Portelinha Filho, et al.
Published: (2009-11-01)

Modeling the Interplay between HDV and HBV in Chronic HDV/HBV Patients
by: Adequate Mhlanga, et al.
Published: (2022-10-01)

HBV and HCV testing outcomes among marginalized communities in Italy, 2019–2024: a prospective studyResearch in context
by: Monica Monti, et al.
Published: (2025-02-01)

Bayesian Analysis of Complex Mutations in HBV, HCV, and HIV Studies
by: Bing Liu, et al.
Published: (2019-09-01)

Bir Şehir Hastanesi Kan Transfüzyon Merkezine Başvuran Donörlerde HBV, HCV, HIV ve VDRL Seroprevalansı
by: Gürkan Muratdağı, et al.
Published: (2019-03-01)

Apulian infectious diseases network: survey on the prevalence of delta infection among chronic HBV carriers in Apulia
by: Massimo Fasano, et al.
Published: (2023-09-01)

The impact of hepatitis B virus (HBV) splicing on HBV replication and disease progression
by: Laura C. McCoullough, et al.
Published: (2024-08-01)

Active immunization against hepatitis B virus (HBV) with low-doses of plasma-derived vaccine by intradermal route
by: Flair José Carrilho, et al.
Published: (1989-04-01)

Epidemiology of Viral Hepatitis in the Indigenous Populations of the Arctic Zone of the Republic of Sakha (Yakutia)
by: Vera S. Kichatova, et al.
Published: (2024-02-01)

Distribution of HCV genotypes among patients attending south Indian tertiary care centre
by: Masood Ahmed Tahashildar, et al.
Published: (2023-04-01)

The Role of Glutathione in Selected Viral Diseases
by: Joanna Wróblewska, et al.
Published: (2023-06-01)

Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis
by: Nghiem Xuan Hoan, et al.
Published: (2021-02-01)

Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen
by: Mary C. Kuhns, et al.
Published: (2021-10-01)

Characterization of the Full-Length Genome Sequences and Phylogenetic Analysis of HDV Strains Isolated from Patients with Chronic HBV and HDV Infection in Kyrgyz Republic
by: Yu. V. Ostankova, et al.
Published: (2020-04-01)

Antiviral activity of zinc against hepatitis viruses: current status and future prospects
by: Shiv Kumar, et al.
Published: (2023-10-01)

HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection
by: Imme Roggenbach, et al.
Published: (2021-09-01)

Pancreatic carcinoma development: new etiological and pathogenetic evidence
by: Sirio Fiorino, et al.
Published: (2013-12-01)

Identification of the Genotypes Circulating in the Ecuadorian Population Infected with the Hepatitis C Virus (HCV)
by: Moncayo M, et al.
Published: (2023-08-01)

Digestive comorbidity in patients with rheumatic diseases: Not only NSAID-induced gastropathy
by: A. E. Karateev, et al.
Published: (2016-10-01)

Alpha-fetoprotein as a predictor of liver disease progression in HBV patients with HIV and HCV co-infections
by: Mathew Folaranmi Olaniyan, et al.
Published: (2024-09-01)

Prevalence of HCV infection and prevalent genotypes of HCV among drug users in Inner Mongolia Autonomous Region, 2022: a sentinel surveillance-based cross-sectional survey
by: Huai ZHANG, et al.
Published: (2024-07-01)

Non-organ-specific autoantibodies with unspecific patterns are a frequent para-infectious feature of chronic hepatitis D
by: Lennart Hermanussen, et al.
Published: (2023-06-01)

The Characteristic of HBV Quasispecies Is Related to Occult HBV Infection of Infants Born to Highly Viremic Mothers
by: Yi Li, et al.
Published: (2024-07-01)

False-seronegative HCV infection motivated by interference with cryoglobulins
by: Recio Comí Gemma, et al.
Published: (2021-04-01)

The Challenge of a Recall Program from a Community-Based Hepatitis C Screening Campaign: The Effectiveness in HCV Microelimination
by: Cheng-Hung Chien, et al.
Published: (2024-07-01)

Anti-HCV, HBsAg Positive Incidences Among Patients Aged 40 Years and Over Diagnosed with B- Non-Hodgkin’s Lymphoma: A Comparison with General Population of Same Age
by: Myagmarjav Budeebazar, et al.
Published: (2019-12-01)

Quantitative characteristics of serum lipoprotein phenotypes for HBV patients
by: YI Xiaoxuan, et al.
Published: (2023-02-01)

Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Giacomo Emanuele Maria Rizzo, et al.
Published: (2022-05-01)

Chronicles of HBV and the Road to HBV Cure
by: Rukaiya Bashir Hamidu, et al.
Published: (2023-04-01)

Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia
by: Yitbarek Wasihun, et al.
Published: (2024-05-01)

Simulation on The Mathematical Model for the Control Of Hepatitis B Virus-Hepatitis D Virus (HBV-HDV) Co-infection Transmission Dynamics in a Given Population
by: Remigius Okeke Aja, et al.
Published: (2021-08-01)